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2296Objectives: The present study investigated the cardioprotective role of urocortin (Ucn) and its relationship with
protein kinase C (PKC)ε and PKCd in patients with (DMPs) and without (NDMPs) diabetes mellitus after
on-pump cardiac surgery (OPCS). The molecular mechanisms responsible for the reported worse outcomes
of DMP after OPCS remain unknown.
Methods: Two sequential biopsy specimens were obtained from the right atrium of 27 DMPs and 22 NDMPs
before and after cardiopulmonary bypass.
Results: Postcardioplegic induction of Ucn in NDMPs (P<.01) was not observed in the DMPs, whose precar-
dioplegic Ucn levels were 50% lower than those in the NDMPs (P<.05). In the NDMPs, cardioplegic arrest
increased PKCεmRNA and protein (P<.05); overexpression of PKCdwas not seen. In contrast, DMPs showed
increased PKCd expression (P<.01), with no change in PKCε. Apoptosis was more than twofold greater in the
postcardioplegic samples from the DMPs than in those from the NDMPs. The apoptotic myocytes were Ucn
negative and exhibited nuclear relocation of PKCd. Enhanced PKCε/mitochondrial co-localization was
observed in viable, Ucn-positive, myocytes. The leakage of troponin I documented in the DMPs was greater
than that in the NDMPs, although the difference was not statistically significant (P¼ .06). Furthermore, despite
a similar incidence of perioperative acute myocardial infarction, the DMPs did not show postoperative improve-
ment of systolic or diastolic function, although that was seen in the NDMPs (P<.05).
Conclusions: Cardioplegic arrest failed to induce in DMPs myocyte overexpression of Ucn or PKCε but was
associated with induction and mitochondrial relocation of PKCd, resulting in apoptosis. Failure to overexpress
Ucn in the DMPs was associated with apoptosis and cardiac dysfunction and, thus, might contribute to worse
postoperative outcomes. (J Thorac Cardiovasc Surg 2014;148:2296-308)See related commentary on page 2309.Diabetes mellitus (DM) is a well-established risk factor for
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The Journal of Thoracic and Cardiovascular Sur(DMPs) account for 28% of all those undergoing coronary
artery bypass grafting (CABG),1 such patients constitute a
larger percentage of the postoperative morbidity and mor-
tality population, with a reported 50% to 90% increase in
mortality among DMPs.1-5 Cardiac pathologic entities
such as myocardial infarction, followed by stroke, were
the most common cause of late mortality after CABG in
DMPs.2 Compared with non-DMPs (NDMPs), the postop-
erative morbidity has also been greater among DMPs,1,6-8
with greater rates of reoperation infection,1-7 a greater
incidence of peri- and postoperative neurologic
complications,6-8 and longer hospitalization periods.1,7 It
has also been reported that cardiopulmonary bypass
(CPB) induces greater oxidative stress in DMPs than in
NDMPs, with quantitatively and qualitatively different
CPB-induced and cardioplegia-induced gene expression
that is potentially responsible for the different inflammatory
reactions in these 2 patient groups.9 Additionally, both
early1,6-8 and late1,3-8,10,11 mortality were greater in DMPs.
Apoptotic cell death has been implicated in the pathogen-
esis of the iatrogenic ischemia–reperfusion (I/R) injurygery c November 2014
Abbreviations and Acronyms
ATP ¼ adenosine triphosphate
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
DM ¼ diabetes mellitus
DMPs ¼ patients with DM
I/R ¼ ischemia–reperfusion
LV ¼ left ventricular
NDMPs ¼ patients without DM
OPCS ¼ on-pump cardiac surgery
PKC ¼ protein kinase C
TUNEL ¼ terminal deoxynucleotidyl transferase
mediated nick end labeling
Ucn ¼ urocortin
WMSI ¼ wall motion score index
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tected using terminal deoxynucleotidyl transferase medi-
ated nick end labeling (TUNEL) staining in myocardial
biopsy specimens from patients undergoing OPCS, with
apoptotic rates of 0.03% and 3% to 6% in ventricular
and atrial samples, respectively.12,13 DM was also
associated with an increased occurrence of apoptotic cell
death, although the underlying molecular mechanisms are
poorly understood.14
Urocortin (Ucn) is a 40-amino acid member of the
corticotrophin-releasing factor family15 endogenously ex-
pressed in the human heart.16 The coexpression of Ucn
and its cognate receptor in cardiac myocytes suggests that
endogenous Ucn might exert autocrine and/or paracrine ef-
fects on the normal and diseased human heart. Biologically
active Ucn, for instance, is released from isolated myocytes
exposed to simulated ischemia and confers cardioprotective
properties on the culture medium that are abrogated by
corticotropin-releasing factor receptor antagonists.17 In
addition, plasma Ucn is increased in the circulation of pa-
tients experiencing acute myocardial infarction.18
We have previously reported that warm blood cardiople-
gia in NDMPs is associated with increased endogenous my-
ocyte expression of Ucn and that Ucn-positive myocytes are
viable but that Ucn-negative cells show evidence of
apoptosis.13 Furthermore, enhanced mitochondrial translo-
cation of protein kinase C (PKC)ε (an established mecha-
nism of Ucn-mediated cardioprotection19), has been
previously observed in viable Ucn-positive myocytes after
cardioplegic arrest.20 In contrast to the cardioprotective
properties of PKCε, however, PKCd expression has been
implicated in apoptosis in a variety of cellular systems,
including the heart.21 Also, hyperglycemia has been shown
to increase both PKCd activation and apoptosis in rat ven-
tricular myocytes in vitro.22The Journal of Thoracic and CarAccordingly, in the present study, we have compared the
induction of Ucn and the activation and translocation of
PKCε and PKCd in DMPs and NDMPs undergoing OPCS.METHODS
Patient Population
The present study strictly conformed to the principles outlined in the
Declaration of Helsinki. The institutional review board of the University
of Verona approved the study, and all patients selected gave informed con-
sent before enrollment. A total of 49 patients (27 DMPs and 22 NDMPs),
who were admitted for elective on-pump CABG, were recruited (Table 1).
All the patients hadmultiple-vessel coronary diseasewith class II-III symp-
toms, according to the Canadian Cardiovascular Society Angina Classifica-
tion. To avoid potential preoperative bias affecting the circulating Ucn level
and the corresponding Ucn-induced intracellular pathways, only patients
with stable angina, a left ventricular ejection (LV) fraction> 40%, and
no significant organ comorbidities, who had been scheduled for isolated
primary CABG, were enrolled in the present study (Table 2).
Surgical Procedure
The anesthesia regimen was standardized and consisted of intravenous
propofol (2 mg/kg) and fentanyl (0.010mg/kg) administration, followed by
propofol infusion (150-200 mg/kg/min) and isoflurane (0.8% inspired con-
centration). Neuromuscular blockade was achieved using 4 mg/h vecuro-
nium bromide. After median sternotomy and heparin (3 mg/kg)
administration, the aorta, right atrium, and inferior vena cava were cannu-
lated. The left internal mammary artery was harvested as a pedicle and was
always anastomosed to the left anterior descending artery. The internal
saphenous vein was always harvested from the best side, which was de-
tected using preoperative clinical evaluation and Doppler scanning. The
management of CPB was standardized and achieved, as previously
described.23 Likewise, cardiac arrest and myocardial protection were stan-
dardized and achieved, as previously described.23 In brief, after aortic
crossclamping, cardiac arrest was induced by cold blood cardioplegia at
4C, injected antegrade for about 3 minutes into the aortic root and then
retrograde for an additional 2 minutes into the coronary sinus. A second
maintenance solution (21mEqKþ/800 mL) at 4Cwas administered retro-
grade every 20 minutes. After completion of the distal anastomosis and
before aortic crossclamp removal, a third reperfusion dose of warm
(37C) blood cardioplegia was administered. The aortic crossclamp was
then removed and construction of the proximal anastomoses begun.
Inotropic drugs were not used until specimen retrieval had been completed.
Tissue Sampling and Preparation
Two sequential biopsy specimens were obtained from a virgin site in the
right atriumby2 highly experienced cardiac surgeons (G.F., A.M.). The first
biopsy was taken as a control sample before starting CPB but before cardi-
oplegia, using a small purse string suture of polypropylene 4-0, stitched on
the middle lateral wall of the right atrium, far from the right appendage and
quite below the superior vena cava atrial junction. The secondwas obtained
as near as possible to the site of the previous sample, about 10 minutes after
release of the aortic crossclamp, using a new purse string suture of polypro-
pylene 4-0, also stitched on the middle lateral right atrial wall.
No clinical complications related to the sampling procedure occurred.
Immediately after collection, each atrial biopsy specimen was cut into 2
parts, as previously described,20 and used for immunofluorescent staining,
RNA isolation, and protein isolation, respectively.
RNA Isolation and Quantitative Polymerase Chain
Reaction
Total RNA was isolated from cardiac samples using an RNA isolator
solution, TRIZol (Gibco-BRL, Sussex, United Kingdom), treated withdiovascular Surgery c Volume 148, Number 5 2297
TABLE 1. Operative details, clinical characteristics, and outcome
data
Variable
DMPs
(n ¼ 27)
NDMPs
(n ¼ 22) P value
Age (y) 63.6  5.0 61.5  3.0 .74
Gender .540
Male 14 12
Female 13 10
HbA1c (%) .001
Mean 8.4 5.9
Range 8.4-8.8 5.8-6.0
Glycemia at admission (mg/dL) .001
Median 163.6 105
Range 163.0-170.0 98.0-105.0
Diabetes duration —
>3 y 6 NA
>10 y 21 NA
Medical management of DM
Oral agents 5 NA
Oral agents plus insulin 14 NA
Insulin 8 NA
Preoperative E 78.2  8.7 74.1  18.7 .3
Preoperative A 81.0  15.2 79.1  17.2 .683
Preoperative E/A 0.9  0.2 0.9  0.2 .399
Preoperative Ea 8.6  1.7 8.9  1.9 .504
Preoperative E/Ea 9.5  2.3 8.8  3.5 .424
Preoperative WMSI 1.36  0.36 1.35  0.43 .914
Preoperative LVEF 52.8  4.2 51.2  2.1 .106
CABG (n) 3.6  0.6 3.8  0.4 .97
Aortic crossclamp time (min)
Median 48.2 49.2 .755
Range 42.0-56.0 49.0-51.0
Preoperative troponin I (mg/L) 0.06  0.10 0.07  0.09 .681
Perioperative AMI 1/27 (3.7) 0/22 (0) .551
Perioperative pneumonia 1/27 (3.7) 1/22 (4.5) .702
Prolonged intubation 2/27 (7.4) 1/22 (4.5) .578
Postoperative AKI 1/27 (3.7) 0/22 (0) .551
Stroke 0/27 (0) 0/22 (0) NA
Data presented as mean  standard deviation or n (%), unless otherwise noted.
DMPs, Patients with diabetes mellitus; NDMPs, patients without DM;HbA1c, hemo-
globin A1c; DM, diabetes mellitus; WMSI, wall motion score index; LVEF, left ven-
tricular ejection fraction; CABG, coronary artery bypass grafting; AMI, acute
myocardial infarction; AKI, acute kidney injury; NA, not applicable.
TABLE 2. Echocardiographic and biochemical results stratified by
group
Variable Preoperative Postoperative P value
DMPs
E 78.2  8.7 78.7  11.5 .881
A 81.0  15.2 71.1  12.6 .008
E/A 0.9  0.2 1.1  0.2 .017
Ea 8.6  1.7 9.0  1.3 .73
E/Ea 9.5  2.3 8.8  1.8 .209
WMSI 1.36  0.36 1.38  0.42 .756
LVEF 52.8  4.2 55.4  7.5 .136
NDMPs
E 74.1  18.7 91.9  9.1 .002
A 79.1  17.2 68.3  12.6 .008
E/A 0.9  0.2 1.4  0.3 .001
Ea 8.9  1.9 10.5  1.7 .002
E/Ea 8.8  3.5 8.8  1.6 .972
WMSI 1.35  0.43 1.17  0.21 .49
LVEF 51.2  2.1 58.6  7.2 .0001
Troponin I levels preoperatively from peripheral blood, intraoperatively at re-
perfusion 10 minutes after aortic declamping and at 6, 12, and 48 hours post-
operatively: for DMPs, 0.06  0.10, 1.52  0.83, 5.38  3.94, 11.09  13.59,
and 14.57  20.76 mg/L (Pa ¼ .0001); for NDMPs, 0.07  0.09, 1.05  0.72,
3.09  1.28, 4.04  4.82, and 5.13  13.53 mg/L (Pa ¼ .001), respectively.
Pb ¼ .037; Pc ¼ .050. DMPs, Patients with diabetes mellitus; WMSI, wall mo-
tion score index; LVEF, left ventricular ejection fraction; NDMPs, patients
without diabetes mellitus; Pa, time P value; Pb, group P value; Pc, group 3
time P value.
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SDNAse (Promega, Madison, Wis), and subsequently reversed transcribed
with Superscript II reverse transcriptase (Gibco BRL, Life Technologies,
Carlsbad, Calif) and oligodT (18-mer) primer.20 Real-time, 1-step poly-
merase chain reaction for specific mRNAwas performed using the Quan-
tiTect SYBR Green polymerase chain reaction kit (Qiagen, Hilden,
Germany) and LightCycler 1.5 instrument (Roche Diagnostics, Indianapo-
lis, Ind), according to the manufacturer’s instructions. The following
specific primers were used to quantitate, by polymerase chain
reaction, the transcript levels of the genes of interest. The Ucn primer
sequences were 50-GCTTGCTGGTGAAAAGGACC-30 (sense) and
50-CTTGCCCACCGAGTCGAAT-30 (antisense). The PKCε primer
sequences were 50-ACCAAGCAGAAGACCAACAG-30 (sense) and 50-
TTCCTATGACACCCCAGATG-30 (antisense). The PKCd sequences
were 50-GGAAGAAGCAATGGTCCAAG-30 (sense) and antisense 50-
GTATTATGTGGGAGAAAATG-30 (antisense).2298 The Journal of Thoracic and Cardiovascular SurImmunoblotting Material and Approach
The types and sources of the antibody used for the immunoblotting pro-
cedurewere as follows. The antibody against actin (matrix protein p84 [heat
shock protein 60]) and total PKCε andPCKdwere obtained fromSantaCruz
Biotechnology (Santa Cruz, Calif). The anti-phospho-PKCε (Ser729) and
anti-phospho-PKCd (Ser665) rabbit polyclonal antibody were purchased
from Upstate Biotechnology (Millipore Corp, Lake Placid, NY). All sec-
ondary antibodies were conjugated to horseradish peroxidase, and the
ensuing immunoreactive bands were developed using a Western lightning
chemiluminescence kit (PerkinElmer Life Science, Waltham, Mass).
Western Blotting
The pre- and postcardioplegic cardiac specimens were homogenized in
lysis buffer (100 mmol/L NaCl, 0.1%Triton X-100, 50 mmol/L Tris;
pH 8.3), loaded on 8% sodium dodecyl sulfate-polyacrylamide gel, separated
by gel electrophoresis, transferred onto a nitrocellulosemembrane, and probed
with relevant primary antibody. The assessment of Ucn protein (molecular
weight, 4693.52 Daltons) was performed as previously described using a Tri-
cine sodium dodecyl sulfate-polyacrylamide gel electrophoresis system.20,24
Mitochondrial, Nuclear, and Cytoplasmic Protein
Fractionation, Characterization, and Assessment
The mitochondrial, nuclear, and cytosolic fractions were prepared using
commercially available kits (mitochondria isolation kit for tissue, Pierce Pro-
tein Research Products, Thermo Fisher Scientific, Rockford, Ill; and nuclear
extraction kit,Millipore,Billerica,Mass), according to themanufacturer’s in-
structions. Equal amounts (20mg) of nuclear,mitochondrial, and cytoplasmic
proteins were separated using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, as previously described,20 and were subsequently probed
with antibody against total and phosphorylated PKCε and PKCd. Anti-
cytochrome oxidase subunit IV, anti-nuclear matrix protein p84, and anti-
actin antibody were used to probe for mitochondrial, nuclear, and cyto-
plasmic fractions, respectively.25gery c November 2014
FIGURE 1. A, Quantitative polymerase chain reaction of urocortin messenger RNA (mRNA) levels in cardiac samples collected before and after cardi-
oplegic (CP) arrest from patients without diabetes mellitus (NDMPs) and patients with diabetes mellitus (DMPs). **P<.01 and *P<.05. B, Expression of
the urocortin protein, as determined by Western blotting of extracts from pre- and post-CP atrial tissues. A total of 54 samples from DMPs (27 taken before
cardioplegia and 27 after release of aortic crossclamping) and 44 samples fromNDMPs (22 obtained before cardioplegia and 22 after release of aortic cross-
clamping) were processed. To obtain adequate amounts of protein and mRNA, the pre- and post-CP samples collected from 3 patients were combined and
processed together, with the exception of 1 pre- and post-CP batch from NDMPs composed of 4 samples. The blot shown is representative of 3 different
blots. Marker proteins with the indicated molecular masses were also used.
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Adjacent 5-mm myocardial sections were stained with TUNEL re-
agents (using a rhodamine fluorochrome) and/or antibody against
Ucn, phosphorylated PKCε, and phosphorylated PKCd. Anti-
cytochrome oxidase subunit IV antibody was used to specifically label
mitochondria. When indicated, the myocardial sections were counter-
stained with propidium iodide or TO-PRO-3 (Life Technologies), as
previously described.13,20,25,26 After washing and incubation with
suitable secondary antibodies (DakoCytomation, Glostrup, Denmark),
the sections were analyzed by a confocal microscopist (T.M.S.), who
was unaware of the origin and sequence of the specimens. The dataThe Journal of Thoracic and Carare expressed as the mean  standard deviation of 12 to 15 high
power fields.
Clinical Data
High-sensitivity troponin I was assayed preoperatively from
peripheral blood, intraoperatively at reperfusion, 10minutes after aortic de-
clamping, and, from the peripheral blood, at 6, 12, and 48 hours
postoperatively.
The LV ejection fraction was calculated using routine transthoracic
echocardiography according to the Simpson method. The wall motion
score index (WMSI) was calculated using the 16-segment model fordiovascular Surgery c Volume 148, Number 5 2299
FIGURE 2. A, Quantitative polymerase chain reaction of protein kinase C (PKC)ε urocortin messenger RNA (mRNA) levels from pre- and postcardio-
plegic (CP) myocardial samples from patients without (NDMPs) and with (DMPs) diabetes mellitus. **P<.01 and *P<.05. B, Expression of total and
phosphorylated PKCε protein, as determined by Western blotting of extracts from nondiabetic and diabetic human hearts before and after CP arrest. A total
of 54 samples from DMPs (27 taken before cardioplegia and 27 after release of aortic crossclamping) and 44 samples from NDMPs (22 obtained before
cardioplegia and 22 after release of aortic crossclamping) were processed. To obtain adequate amounts of proteins and mRNA, pre- and post-CP samples
collected from 3 different patients were combined and processed together, with the exception of 1 pre- and post-CP batch from NDMPs composed of 4
samples. The data shown are representative of 3 different experiments.
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SLV segmentation, as recommended by the American Society for Echocar-
diography,27 before admission to the operating room and at 96 hours
postoperatively. The LV myocardial velocities were also recorded at
the mitral annulus using pulsed-wave tissue Doppler imaging to investi-
gate perioperative diastolic function, at the same measurement points2300 The Journal of Thoracic and Cardiovascular Sur(before admission to the operating room and 96 hours postoperatively)
used for WMSI.28
The other data collected included age, gender, hemoglobin A1c, and
serum glycemia at admission; number of CABG procedures; aortic cross-
clamp time; percentage of patients with perioperative acute myocardialgery c November 2014
Chen-Scarabelli et al Evolving Technology/Basic Scienceinfarction; prolonged (>48 hours) ventilation; and incidence of pneumonia,
acute renal insufficiency, and stroke.
Statistical Analysis
For the molecular data, significance was evaluated using the 2-tailed t
test. For the baseline data and clinical characteristics, the continuous vari-
ables were first tested for normality using the Shapiro-Wilk test and then
compared using the Student t test or Mann Whitney U test, accordingly.
The categorical variables were compared using the Fisher exact test and
ordinal variables using the Mann Whitney U test.
Repeatedmeasures analysis of variancewith Bonferroni’s correction for
multiple measurements was used to compare serial data related to periop-
erative troponin I leakage. The reported P values include ‘‘Pa’’ (time-P),
assessing change over time of the measured variable; ‘‘Pb’’ (group-P), as-
sessing the level of difference between groups; and ‘‘Pc’’ (group3 time P)
assessing the group–time interaction. The paired samples t test was used to
investigate the perioperative changes of the echocardiographic data. Statis-
tical analysis was performed using the Statistical Package for Social Sci-
ences program for Windows, version 15.0 (SPSS, Inc, Chicago, Ill).E
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In line with our previous findings, the hearts from
NDMPs exposed to cardioplegic arrest and subsequent re-
perfusion exhibited a significant induction of Ucn at both
the mRNA (268% of basic levels; P<.01) and the protein
(threefold increase; P<.0026) level. In contrast, the hearts
from the DMPs showed a significantly lower basal expres-
sion of Ucn at RNA (50% lower) and protein (85% lower)
levels (P<.05 vs NDMP basal levels) that was not signifi-
cantly increased by OPCS (P¼ NS; Figure 1). In the hearts
from DMPs, cardioplegic arrest was associated with
increased transcription of PKCε mRNA (230% of internal
control; P<.05) and a threefold increased expression of to-
tal PKCε protein (P<.05), with a 4.2-fold increase in phos-
phorylated PKCε (P<.01). In contrast, in the hearts of the
DMPs, the precardioplegic level of PKCε mRNA, which
was approximately 30% lower than that of the hearts of
the NDMPs, did not increase after cardioplegic arrest. Simi-
larly, total PKCε protein was not augmented after cardiople-
gic arrest in the DMPs nor was any increase in PKCε
phosphorylation detected (Figure 2).
In the hearts of the NDMPs, PKCdwas detectable at both
the mRNA and the protein level; however, OPCS did not
result in any increase in the levels of the transcript, total pro-
tein, or its phosphorylation. In contrast, as depicted in
Figure 3, the DPMs’ hearts showed a baseline expression
of PKCd that was significantly greater at the mRNA and
protein levels than that in the NDMPs’ control hearts and
was further increased after cardioplegia (mRNA, 269% of
basic level; protein, 2.4-fold increase; P < .01), along
with enhanced PKCd phosphorylation (Figure 3).
Apoptotic cell death, assessed by TUNEL staining, was
more than twofold greater in the postcardioplegic samples
from the DMPs (6.5%  1.8%) than that in the
NDMPs (2.9% 0.7%; Figure 4, A). Nuclear translocation
of PKCd (2.4-fold increase) was only seen in theThe Journal of Thoracic and Carpostcardioplegic samples from DMPs (Figure 4, B, and
Table 3) but not in the samples from the NDMPs (data
not shown).
Cardiac cells showing cytosolic staining for Ucn never
exhibited nuclear relocation of PKCd or TUNEL-positive
staining (Figure 5, A). Furthermore, co-localization of nu-
clear PKCd and TUNEL positivity was consistently seen
in Ucn-negative myocytes (Figure 5, B, and Table 4).
In contrast, mitochondrial relocation of PKCε was
only detected in postcardioplegic samples from the
NDMPs. In line with our previous findings,18 PKCε/
mitochondria co-localization was observed in viable my-
ocytes showing positive staining for Ucn (Figure 5, A-D,
and Table 4).Clinical Data
The clinical baseline and operative data proved compa-
rable between the 2 groups, with the exception of the
baseline serum glycemic value and percentage of hemo-
globin 1c, which were greater in the DMPs (Table 1).
No differences were recorded in the baseline serum
troponin I or in any of the preoperative echocardiographic
systolic and diastolic indexes (Table 1). A similar clinical
outcome was also evident in terms of the incidence of
perioperative acute myocardial infarction, pneumonia,
prolonged ventilation, and acute renal insufficiency
(Table 1). No stroke events were seen during the study
period.
However, when perioperative leakage of troponin I was
considered, both groups demonstrated a time-dependent in-
crease in postoperative troponin I, although the DMPs had,
overall, significantly greater leakage than did the NDMPs
(Table 2).
Furthermore, despite a similar incidence of perioperative
acute myocardial infarction, the DMPs did not show any
improvement in their systolic function (using both the
WMSI and LV ejection fraction), which was significantly
improved in the NDMPs (Table 2). Similarly, the echocar-
diographic indexes of diastolic function in the DMPs re-
mained comparable (with the exception of the E/A ratio)
between the preoperative and postoperative periods, but
almost all had improved significantly in the NDMPs after
surgery (Table 2).DISCUSSION
The mechanisms by which DM heightens the morbidity
and mortality associated with OPCS are poorly understood.
However, blood glucose levels seem to play a role, because
hyperglycemia was found to influence long-term survival
after CABG2,29 and was an independent risk factor for
mortality in patients undergoing cardiac surgery.30 Like-
wise, stricter perioperative glucose control was shown to
reduce mortality in DMPs undergoing CABG.31-33diovascular Surgery c Volume 148, Number 5 2301
FIGURE 3. A, Quantitative polymerase chain reaction of protein kinase C (PKC)d urocortin messenger RNA (mRNA) levels from pre- and post-
cardioplegic (CP) myocardial samples of patients without (NDMPs) and with (DMPs) diabetes mellitus. **P<.01 and *P<.05. B, Western blotting of
extracts from nondiabetic and diabetic human hearts before and after cardioplegic arrest showing expression of total and phosphorylated PKCd protein.
A total of 54 samples from DMPs (27 taken before cardioplegia and 27 after release of aortic crossclamping) and 44 samples from NDMPs (22 obtained
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SMoreover, both preoperative2,34 and postoperative35 hyper-
glycemia have been reported as important predictors of late
mortality after CABG. A recent report by Voisine and col-
leagues9 clearly showed qualitative and quantitative differ-
ences in gene expression profiles from cardiac myocytes of
DMPs compared with NDMPs, in particular, those related
to the inflammatory response and oxidative stress after
CPB with cardioplegic arrest. However, the molecular
mechanisms activated in DM after cardioplegic arrest that
contribute to the worse periprocedural outcomes for this
high-risk cohort of patients remain poorly understood.
The molecular mechanisms reported in the present study
could contribute to a better understanding and improved
management of the response of the DM heart to cardiople-
gic arrest.
In addition to inducing oxidative stress and negative ino-
tropism in the heart,22 hyperglycemia has been found to
induce mitochondrial dysfunction, cytochrome-c release,
and apoptosis.36 Hyperglycemia is a powerful activating
signal for cardiac PKC isozymes, which in turn have been
associated with modulation of apoptosis.22 In primary cul-
tures of serum-starved adult rat ventricular myocytes, hy-
perglycemia induced apoptotic cell death, which was
attenuated by administration of peptide inhibitors of PKC
beta-I/beta-2, and zeta, although not PKCε (epsilonV1-2).22
In contrast, the PKCε translocation activator (psi epsilon
RACK) abolished hyperglycemia-induced apoptosis,
strongly suggesting a cardioprotective role for PKCε in
hyperglycemia-induced apoptosis.36
Activation of PKCd, another PKC isoform, has been re-
ported in ventricular myocytes under hyperglycemic condi-
tions.22 In adult rat ventricular myocytes, treatment with
hyperglycemia (16.5 mM) for 24 hours resulted in a greater
than threefold increase in apoptosis compared with baseline
and in membrane translocation and activation of PKCd.22
Hyperglycemia-induced apoptosis was attenuated by the
PKCd-specific translocation inhibitor peptide (deltaV1-
1).22,32 In an isolated perfused rat heart model of I/R
injury, the inhibition of PKCd prevented reperfusion
injury, and activation of PKCε mimicked ischemic
preconditioning, confirming the opposite effects exerted
in vitro and ex vivo by PKCd and PKCε in the context of
I/R injury.36
In our study, we have shown for the first time that, in the
hearts of DMPs, the baseline cardiomyocyte expression of
Ucn, a well-known cardioprotective agent, is roughly one
half that in the hearts of NDMPs. Also, in contrast to the
NDMP hearts, it was not increased after cardioplegia. Thebefore cardioplegia and 22 after release of aortic crossclamping) were processed
plegic samples collected from 3 different patients were combined and processed
composed of 4 samples. The data shown are representative of 3 different exper
The Journal of Thoracic and Carreduced Ucn in the hearts of the DMPs was associated,
not only with a reduced baseline expression of PKCε, which
failed to relocate after cardioplegic arrest, but also by over-
expression of PKCd, whose postcardioplegic translocation
to the nuclei was seen in apoptotic myocytes. We previously
reported that human hearts exposed tomild forms of surgical
ischemia exhibited PKCε phosphorylation and mitochon-
drial translocation, which promoted cell survival, but only
inmyocytes expressingUcn. Thus, a low baseline Ucn level,
together with an inability to increase its expression after car-
dioplegic arrest, can contribute to making diabetic hearts
more susceptible to apoptosis, which would, in turn,
contribute to adverse postoperative outcomes.
Different volatile anesthetics, including isoflurane,
have been shown to provide cardioprotection in patients
undergoing CABG with CPB.37 The mechanism of
anesthetic-induced cardioprotection seems to be related to
PKCε-induced preconditioning by delayed opening of the
mitochondrial permeability transition pore.38,39 Because
all the patients enrolled in our study received the same
anesthesia regimen, it is possible that DMPs might benefit
to a lesser extent from anesthetic-induced cardioprotection
owing to the low preoperative levels and the lack of postop-
erative induction of PKCε.
We have previously shown that in the rat heart exposed to
I/R injury, Ucn exerts a cytoprotective action that is indepen-
dent of an energy-sparing mechanism secondary to a nega-
tive inotropic effect and is associated with both recovery
of cardiac performance and reduced depletion of endoge-
nous high-energy phosphates.40 The degree of cardiac
dysfunction after I/R injury reflects the level of myocyte
injury and death. Cell death after injury, and the form that
it takes, is largely dependent on the intracellular adenosine
triphosphate (ATP) levels and other high energy phos-
phates.41 For example, viable cells will have an ADP/ATP
ratio of<0.11, apoptotic cells a ratio of 0.11 to 1.0, and
necrotic cells, a ratio of 15.42 The Ucn-induced recovery
of ATP stores, with a reduction of the intracellular ADP/
ATP ratio, might allow damagedmyocytes that would other-
wise die by necrosis to die by the alternative apoptotic
pathway. Because necrosis, unlike apoptosis, is associated
with the release of intracellular contents and a subsequent in-
flammatory reaction, a reduction in the proportion of
necrotic death will result in a smaller final lesion, with func-
tional benefit. The greater troponin release and the doubled
percentage of apoptotic cell death documented in the DMPs
would be consistent with this interpretation. Accordingly,
supplementation of cardioplegic solutions with exogenous. To obtain adequate amounts of proteins and mRNA, pre- and postcardio-
together, with exception of 1 pre- and postcardioplegic batch from NDMPs
iments.
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FIGURE 4. A, Occurrence of apoptotic cell death as assessed by terminal deoxynucleotidyl transferase mediated nick end labeling (TUNEL) staining at the
end of cardioplegic (CP) arrest in myocardial sections from the hearts of patients without (NDMPs) and with (DMPs) diabetes mellitus. A total of 5 different
sections for each collected sample were analyzed. Data are expressed as the mean  standard deviation of 12 to 15 high-power fields. B, Nuclear and
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TABLE 3. Percentages of cardiac cells with positive labeling for pPKCε, pPKCd, urocortin, and TUNEL in DMPs and NDMPs before and after
cardioplegic arrest
pPKCε-positive
cytosol
pPKCd-positive
cytosol
pPKCε/mitochondria
co-localization
pPKCd/nuclei
co-localization
Urocortin-positive
myocytes TUNEL
DMPs NDMPs DMPs NDMPs DMP NDMP DMP NDMP DMP NDMP DMP NDMP
Before CP 2.7  0.3 7.1  0.8 6.8  1.1 1.6  0.3 0.8  0.3 2.4  0.4 0.9  0.2 <0.1 0.9  0.3 2.7  0.5 1.2  0.4 <0.1
After CP 3.4  0.4 26.7  3.7 19.3  2.8 2.2  0.5 1.4  0.5 22  2.8 7.9  1.8 3.3  0.5 1.6  0.5 23  2.6 6.4  1.3 2.9  0.6
P value* .039 .019 .023 .069 .042 .002 .009 .019 .062 .003 .006 .037
Data presented as mean percentage  standard deviation of 12-15 high power fields. Five different sections for each collected sample were analyzed. pPKC, Phosphorylated
protein kinase C; TUNEL, terminal deoxynucleotidyl transferase mediated nick end labeling; DMPs, patients with diabetes mellitus; NDMPs, patients without diabetes mellitus;
CP, cardioplegia. *Postcardioplegic specimens versus corresponding precardioplegic samples.
Chen-Scarabelli et al Evolving Technology/Basic ScienceUcn warrants investigation to enhance the intrinsic cardio-
protective mechanisms of the diabetic heart, thus reducing
the risk of postoperative cardiac dysfunction in DMPs
exposed to the inescapable I/R injury associatedwith OPCS.E
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The main clinical finding of the present study was that
despite a similar clinical outcome between the DMPs and
NDMPs (documented by the negligible and comparable
incidence of perioperative acute myocardial infarction,
pneumonia, acute renal insufficiency, and the need for pro-
longed intubation), DMPs had greater perioperative
troponin I leakage and suboptimal echocardiographic re-
sults. It is well known that perioperative troponin I leakage
reflects the quality of myocardial protection and that its
value has prognostic implications for mid- to long-term
follow-up.43,44 Furthermore, variable degrees of
myocardial damage with systolic dysfunction will occur
even after successful myocardial revascularization because
of iatrogenic myocardial I/R injury.9,43,45 Accordingly,
suboptimal myocardial protection strategies, as shown by
the molecular results reported in the present study and
further documented by the perioperative troponin I
leakage, might help to understand the worse prognosis of
DMPs compared with NDMPs reported in published
studies.1,5-8 The greater perioperative troponin leakage
also helps to understand why the DMPs did not show any
postoperative recovery in the WMSI and LV ejection
fraction,43,44 the opposite of that seen in the NDMPs.
It has recently been demonstrated that DMPs have greater
post-CABG diastolic dysfunction compared with
NDMPs,46 with a linear correlation between the duration
of DM,47 and that both diastolic46,48 and systolic49 dysfunc-
tion after CABG significantly impair outcome. Moreover,
contradictory results for LV diastolic function after CABG
have been reported. Hedman and colleagues28 showed early
improvement of diastole after CABG. However, Diller andmitochondrial translocation of protein kinase C (PKC)d in the human heart exp
cardiac samples of NDMPs and DMPs collected before and after CP. Matrix pro
specific markers of the nuclear, mitochondrial, and cytosolic fractions, respecti
=
The Journal of Thoracic and Carcolleagues50 demonstrated early improvement followed by
a late decline of LV relaxation that had reached the preoper-
ative values within 18 months postoperatively. Other inves-
tigators have found CPB-related early impairment of LV
relaxation.51 Our data could help to clarify these contradic-
tory results, because myocardial relaxation during diastole
is an energy-dependent process requiring an effective oxy-
gen supply28; therefore, less adequate techniques of
myocardial protection or a less effective ability to resist
ischemia and ischemia–reperfusion during the crossclamp
time or at reperfusion, respectively, could induce myocar-
dial contracture.52,53 Thus, it could be expected that
myocardial tissues unable to adequately counteract
ischemia and I/R injury, such as the myocardial cells of
DMPs, would show impaired postoperative relaxation,
resulting in LV diastolic dysfunction. Thus, the absence of
any postoperative recovery from the preoperative diastolic
dysfunction seen in our series of DMPs can be considered
the net result between the beneficial effects of myocardial
revascularization and the deleterious effects of
preoperative ischemia and intraoperative I/R injury,
together with a ‘‘less adequate’’ strategy of myocardial
protection during the crossclamp time (ie, a less adequate
capacity to counteract the unavoidable intraoperative I/R
injury). Therefore, given the comparable preoperative
status and the similar successful myocardial
revascularization in both groups, the worse diastolic
function of the DMPs can be ascribed to a worse ability of
the myocardial cells to withstand I/R injury. More studies
are mandatory to better understand the clinical effect of
these molecular mechanisms. However, the results from
the present study have confirmed the urgent need for
improved myocardial protection strategies for DMPs
referred for CABG, given the profound effect on outcome
of high troponin leakage43,44 and any decline in
postoperative systolic and/or diastolic function.47-49 The
increasing knowledge of the molecular mechanismsosed to CP arrest as assessed by Western blotting in protein extracts from
tein p84, cytochrome oxidase subunit IV (COX IV), and actin were used as
vely.
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FIGURE 5. Two adjacent 5-mm myocardial sections serially cut from the same postcardioplegic wax block of a patient with diabetes. The sections were
stained with (A) an antibody against urocortin (white asterisk) and rhodamine-based terminal deoxynucleotidyl transferase mediated nick end labeling
(TUNEL) reagents (white arrow) or (B) an antibody against phosphorylated protein kinase C (PKC)d (yellow arrow). Secondary antibodies conjugated
with fluorescein were used to label the primary antibody against urocortin (A, bright green cytosol) and phosphorylated PKCd (B, bright green nuclei).
A, Urocortin-negative cells were TUNEL negative, but, (B) adjacent urocortin-negative cells with apoptotic nuclei stained red by TUNEL reagents also ex-
hibited nuclear translocation of PKCd. A total of 54 samples from diabetic patients (27 taken before cardioplegia and 27 after release of aortic crossclamping)
and 44 samples from nondiabetic patients (22 obtained before cardioplegia and 22 after release of aortic crossclamping) were processed. Five different sec-
tions for each collected sample were analyzed. A and B, The images depicted were representative of 27 myocardial samples harvested from diabetic patients
after cardioplegic arrest. Data are expressed as the mean standard deviation of 12 to 15 high-power fields. Myocardial sections from atrial tissues collected
from a nondiabetic patient after cardioplegic arrest. C, The first section was stained with primary antibody against urocortin and a secondary antibody con-
jugated with fluorescein. Positive cells appear bright green. D, The second section was stained with 2 different primary antibodies (anti-cytochrome oxidase
subunit IV [COX IV], a specific mitochondrial marker, and anti-phosphorylated PKCε) and finally counterstained with the nuclear marker TOPRO-3 (blue
staining). COX IV stained bright red by a secondary antibody conjugated with rhodamine. E, PKCε stained bright green by a secondary antibody conjugated
with fluorescein. F, An overlay of the 3 stains is shown. The percentage of co-localization of phosphorylated PKCε andmitochondria was digitally quantified
using image analyzer software. D, Visually, an overlap of ‘‘green’’ phosphorylated PKCε and ‘‘red’’ mitochondria resulted in a bright orange fluorescent
signal that could be observed in themerged images. Five different sections for each collected samplewere analyzed.C-F,Representative images of 22myocar-
dial samples harvested from nondiabetic patients after cardioplegic arrest. Data are expressed as themean standard deviation of 12 to 15 high-power fields.
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effects of Ucn, possibly incorporated into cardioplegic2306 The Journal of Thoracic and Cardiovascular Sursolutions, on the intracellular pathways modulating
post-CABG myocardial cell survival and apoptosis could
positively affect the post-CABG outcome of DMPs.gery c November 2014
TABLE 4. Association of PKCεmitochondrial relocation and PKCd nuclear relocation with urocortin and TUNEL staining inmyocardial samples
after cardioplegic arrest
Myocytes
Post-CP pPKCε/mitochondria co-localization Post-CP pPKCd/nuclei co-localization
DMPs NDMPs DMPs NDMPs
Overall co-localization 1.4  0.5; P ¼ .048 22  2.8; P ¼ .0001 7.9  1.8; P ¼ .016 3.3  0.5; P ¼ .042
Urocortin
Positive 1.1  0.3; P ¼ .00033 18  2.1; P ¼ .00028 <0.1; P ¼<.00001 <0.1; P ¼<.00001
Negative 0.3  0.2; P ¼ .00018 4  0.6; P ¼ .00027 7.9  1.8; P ¼<.00001 3.3  0.5; P ¼<.00001
TUNEL
Negative 1.4  0.5; P ¼ 1 22  2.8; P ¼ 1 1.5  0.4; P ¼ .048 0.4  0.2; P ¼ .0023
Positive <0.1; P<.00001 <0.1; P<.00001 6.4  1.3; P ¼ .0023 2.9  0.6; P ¼ .0041
Data in percentages presented as mean  standard deviation of 12-15 high-power fields. Five different sections for each collected sample were analyzed. PKC, Protein kinase C;
TUNEL, terminal deoxynucleotidyl transferase mediated nick end labeling; CP, cardioplegia; DMPs, patients with diabetes mellitus; NDMPs, patients without diabetes mellitus.
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One potential limitation of our study was the use of atrial
rather than ventricular specimens. However, the choice of
atrial tissue was dictated by ethical constraints, because
atrial, unlike ventricular, biopsy carries no significant
morbidity and provides full-thickness samples that are
readily reproducible. Although the atrial myocardium dif-
fers from the ventricular myocardium with respect to the
relative percentage of myocyte, endothelial, connective,
and neural elements, all these cell types are also present
in ventricular tissue and demonstrate similar ultrastructural
changes in human heart disease.9 It has also been shown that
the gene profiles show similar patterns of expression in both
ventricular and atrial tissue before and after cardioplegic
arrest.9
Finally, the present study was not intended for clinical
purposes; therefore, the related clinical results must be
considered as descriptive only (our study was underpow-
ered to detect differences in the major clinical outcome
variables).
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